{
    "additionDate": "2021-01-18T08:38:16Z",
    "biotoolsCURIE": "biotools:sars-cov-2",
    "biotoolsID": "sars-cov-2",
    "confidence_flag": "tool",
    "credit": [
        {
            "email": "drashutoshkumar@aiimspatna.org",
            "name": "Ashutosh Kumar",
            "typeEntity": "Person"
        },
        {
            "email": "maitism@rediffmail.com",
            "typeEntity": "Person"
        },
        {
            "email": "bamrita.bioinfo@gmail.com",
            "typeEntity": "Person"
        },
        {
            "email": "xqian@shmu.edu.cn",
            "name": "Xu Qian",
            "typeEntity": "Person"
        },
        {
            "email": "hantieru@hotmail.com",
            "name": "Tie-Ru Han",
            "typeEntity": "Person"
        },
        {
            "email": "jrgreen@sce.carleton.ca",
            "name": "James R. Green",
            "typeEntity": "Person"
        },
        {
            "email": "trevor@oncoimmunity.com",
            "name": "Trevor Clancy",
            "typeEntity": "Person"
        },
        {
            "email": "m.g.semple@liverpool.ac.uk",
            "typeEntity": "Person"
        },
        {
            "email": "costas@psu.edu",
            "name": "Costas D. Maranas",
            "typeEntity": "Person"
        }
    ],
    "description": "Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients.\n\nEnergetics based epitope screening in SARS CoV-2 (COVID 19) spike glycoprotein by Immuno-informatic analysis aiming to a suitable vaccine development.\n\na practice of building a community with a shared future for mankind.\n\nComputational Prediction of the Comprehensive SARS-CoV-2 vs. Human Interactome to Guide the Design of Therapeutics.\n\nArtificial intelligence predicts the immunogenic landscape of SARS-CoV-2.\n\nIdentification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening.\n\nDe novo design of high-affinity antibody variable regions (Fv) against the SARS-CoV-2 spike protein.\n\nSevere Acute Respiratory Syndrome (SARS).",
    "editPermission": {
        "type": "private"
    },
    "function": [
        {
            "operation": [
                {
                    "term": "Peptide immunogenicity prediction",
                    "uri": "http://edamontology.org/operation_0252"
                },
                {
                    "term": "Epitope mapping",
                    "uri": "http://edamontology.org/operation_0416"
                },
                {
                    "term": "Protein interaction prediction",
                    "uri": "http://edamontology.org/operation_2492"
                },
                {
                    "term": "Molecular docking",
                    "uri": "http://edamontology.org/operation_0478"
                },
                {
                    "term": "Genotyping",
                    "uri": "http://edamontology.org/operation_3196"
                }
            ]
        }
    ],
    "homepage": "https://www.proteinatlas.org/humanproteome/sars-cov-2",
    "lastUpdate": "2021-02-11T16:15:04.483647Z",
    "license": "CC-BY-4.0",
    "link": [
        {
            "type": [
                "Other"
            ],
            "url": "https://www.who.int/csr/sars/en/"
        }
    ],
    "name": "SARS-CoV-2",
    "owner": "zsmag19",
    "publication": [
        {
            "doi": "10.1101/2020.04.14.040204"
        },
        {
            "doi": "10.1101/2020.04.02.021725"
        },
        {
            "doi": "10.1186/S40249-020-00650-1",
            "metadata": {
                "authors": [
                    {
                        "name": "Qian X."
                    },
                    {
                        "name": "Ren R."
                    },
                    {
                        "name": "Wang Y."
                    },
                    {
                        "name": "Guo Y."
                    },
                    {
                        "name": "Fang J."
                    },
                    {
                        "name": "Wu Z.-D."
                    },
                    {
                        "name": "Liu P.-L."
                    },
                    {
                        "name": "Han T.-R."
                    }
                ]
            },
            "pmcid": "PMC7137400",
            "pmid": "32264957"
        },
        {
            "doi": "10.1101/2020.03.29.014381"
        },
        {
            "doi": "10.1101/2020.04.21.052084"
        },
        {
            "doi": "10.1101/2020.04.23.20076042",
            "pmid": "33196625"
        },
        {
            "doi": "10.1101/2020.04.09.034868"
        }
    ],
    "topic": [
        {
            "term": "Immunogenetics",
            "uri": "http://edamontology.org/topic_3930"
        },
        {
            "term": "Surgery",
            "uri": "http://edamontology.org/topic_3421"
        },
        {
            "term": "Molecular interactions, pathways and networks",
            "uri": "http://edamontology.org/topic_0602"
        },
        {
            "term": "Immunoinformatics",
            "uri": "http://edamontology.org/topic_3948"
        },
        {
            "term": "Machine learning",
            "uri": "http://edamontology.org/topic_3474"
        }
    ]
}